BioSpace News Archive

Quotacy finds putting families before profits and a do-the-right-thing mindset to be the key to their continued success.

Livongo Health, Inc. (NASDAQ: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of a study that demonstrated people with both diabetes and high blood pressure who used the Livongo for Hypertension solution and the Livongo for Diabetes solution

Viome, a mission-driven company aiming to improve people’s health based on individual biology, today announced a partnership with GSK, the world’s leading vaccine company, to increase understanding of chronic diseases and a potential role for vaccines.

Persona™, a Nestlé Health Science (NHSc) company and leading personalized vitamin subscription program, announced today the launch of its nutrition academic scholarship program, which offers two $1,000 academic scholarships to those studying to become a registered dietitian or nutritionist.

Analysis Group, a global leader in health economics and outcomes research (HEOR), and the Institute of Hematology & Blood Diseases Hospital (IHBDH), a clinical and research institute of the Chinese Academy of Medical Sciences and Peking Union Medical College, will partner to create China’s first comprehensive blood disease research platform

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, today announced financial results for the third quarter of 2019, ended September 30, 2019.

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced its Spectrum Two™ FT-IR spectrometer solution is onboard a research trip led by eXXpedition, a not-for-profit organization running all-women sailing voyages investigating ocean plastic pollution causes and solutions.

Tauriga Sciences, Inc. announced that it is in discussions with multiple international distributors to expand its Tauri-Gum™ brand internationally.

Valoctocogene Roxaparvovec on Track for US and EU Regulatory Submissions by Year End

There’s an important new global standards initiative that quietly launched on December 16th in the BioPharma regulatory area called the OASIS eTMF Standard.